XRTX
NASDAQ · Pharmaceuticals
Xortx Therapeutics Inc
$2.09
+0.06 (+2.96%)
Open$2.11
Previous Close$2.03
Day High$2.11
Day Low$2.09
52W High$9.85
52W Low$2.42
Volume—
Avg Volume1.3K
Market Cap5.16M
P/E Ratio—
EPS$-2.65
SectorPharmaceuticals
Analyst Ratings
Strong Buy
5 analysts
Price Target
+1,940.1% upside
Current
$2.09
$2.09
Target
$42.64
$42.64
$28.32
$42.64 avg
$47.79
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 73.23M | 91.76M | 1.25M |
| Net Income | -6,927,602 | -7,812,106 | 338.7K |
| Profit Margin | -2.6% | -2.5% | 27.0% |
| EBITDA | -8,203,869 | -9,765,286 | 499.5K |
| Free Cash Flow | — | — | 161.5K |
| Rev Growth | -20.2% | -20.2% | +20.7% |
| Debt/Equity | 0.02 | 0.02 | 0.65 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |